Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline effects on serum prolactin and quality of life in chronic migraine
IRCT20211013052758N1Phase 2Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of amitriptyline in chronic migraine, sponsored by Semnan University of Medical Sciences. Primary endpoints: Effect of serum prolactin changes on quality of life after amitriptyline treatment, Serum prolactin level change and 2 more. Started Nov 2021; status: completed.
02
Drugs
amitriptyline
03
Conditions
chronic migraine
Beyond the preview
Go deeper on IRCT20211013052758N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211013052758N1.